19 June 2013
Keywords: Drug approval rates, USA, Europe, Oncology versus non-cancer drugs, Tufts CSDD
Article | 05 September 2012
Approval times for new oncology drugs in the USA during the last decade were shorter than those for non-oncology products, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
5 September 2012
18 June 2013
© 2013 thepharmaletter.com